GEOapplication/xmlftp://ftp.ncbi.nlm.nih.gov/geo/series/GSE316nnn/GSE316424/primaryOK200GenomicsHomo sapiensNon-coding RNA profiling by high throughput sequencinghttps://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE316424GEOGSEfalseCetuximab or panituximab differentially impact miRNA expression and potential signaling pathway in cancer colon HCT116 or HT29 cells in vitroAiming to understaned resistance to monocolonal antibodies (Cetuximab, Ctx or Panituximab, Pani) in colon cancer cells, miRNA were studies in both HT29 cells(B-RAF mutated, moderattely-sensitive to Ctx) and HCT116 (K-RAS mutated, highly resistant to Ctx)2026/05/04GSE316424GSM9453048GSM9453049GSM9453046GSM9453047GSM9453051GSM9453052GSM9453050GSM9453045GSM9453053GSM945305418573316424Homo sapiens[42027771]